tyrosine has been researched along with fibrinogen in 193 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 65 (33.68) | 18.7374 |
| 1990's | 42 (21.76) | 18.2507 |
| 2000's | 63 (32.64) | 29.6817 |
| 2010's | 21 (10.88) | 24.3611 |
| 2020's | 2 (1.04) | 2.80 |
| Authors | Studies |
|---|---|
| Altekar, W | 3 |
| Carmack, C; Geokas, MC; Rinderknecht, H | 1 |
| Odeberg, H; Olsson, I; Venge, P | 1 |
| Kierulf, P; Ly, B | 1 |
| Jollès, P; Kaye, NM | 1 |
| Blombäck, B; York, JL | 1 |
| Blombäck, B; Inada, Y | 1 |
| Vinazzer, H | 1 |
| Colvin, RB; Dvorak, HF | 1 |
| Kemler, V; Pilgeram, LO; von dem Bussche, G | 1 |
| Budzynski, AZ; Marder, VJ; Sherry, S | 1 |
| Gorman, JJ | 1 |
| Budzynski, AZ; Marder, VJ | 1 |
| Chanderkar, LP; Gurnani, S; Nadkarni, GB | 1 |
| Brugge, JS; Cobb, BS; Haimovich, B; Lipfert, L; Parsons, JT; Schaller, MD | 1 |
| Bodary, SC; Levinson, AD; Pelletier, AJ | 1 |
| Duggan, ME; Egbertson, MS; Halczenko, W; Hartman, GD; Laswell, WL; Lynch, RJ; Manno, PD; Naylor, AM; Smith, RL; Zhang, G | 1 |
| Doolittle, RF; Yamazumi, K | 1 |
| Brugge, JS; Golden, A; Shattil, SJ | 1 |
| Chung, DW; Davie, EW; Farrell, DH; Huang, SM; Mulvihill, ER | 1 |
| Han, JR; Liu, CC; Liu, MC; Lu, RL; Suiko, M; Tang, XB | 1 |
| Lipmann, F; Liu, MC; Redman, CM; Sy, J; Yu, S | 1 |
| Hortin, GL | 1 |
| Henschen, A; Lucas, J | 1 |
| Hirose, S; Ikehara, Y; Oda, K | 1 |
| Barling, PM; Christie, DL; Hill, RM; Isakow, K | 1 |
| Arnesen, H; Kierulf, P; Ly, B | 1 |
| Gravem, K; Jakobsen, E; Kierulf, P; Ly, B | 1 |
| Cottrell, BA; Doolittle, RF | 1 |
| Bion, N; Marguerie, G; Suscillon, M | 1 |
| Guinebault, PR; Mester, L; Szabados, L | 1 |
| Carrington, CE; Davey, FR; Nelson, DA | 1 |
| Krohn, K; Sherman, L; Welch, M | 1 |
| Kierulf, P | 2 |
| Harrison, JH; Lundblad, RL; Mann, KG | 1 |
| Phillips, HM; York, JL | 1 |
| Edelhoch, H; Lamas, L; Salvatore, G; Taurog, A | 1 |
| Murray, M; Rearick, DE | 1 |
| Chien, S; Dellenback, RJ | 1 |
| Regoeczi, E; Walton, PL | 1 |
| Dickinson, P; Doe, RP; Seal, US; Swaim, WR; Zinneman, HH | 1 |
| Murray, M; Smith, GF | 1 |
| Godal, HC; Kierulf, P | 1 |
| Harrison, JH; Lundblad, RL | 1 |
| Everett, H; Gollub, S; Hirose, T | 1 |
| Gerbeck, CM; Montgomery, R; Yoshikawa, T | 1 |
| Capet-Antonini, FC; Guinand, S | 1 |
| Cartwright, T; Kekwick, RG | 1 |
| Gershoff, SN; Gill, TJ; Simonian, SJ | 1 |
| Mihalyi, E | 1 |
| Huseby, RM; Murray, MM | 1 |
| Bengmark, S; Hafstrom, LO; Korsan-Bengtsen, K | 1 |
| Liener, IE; Mills, DA | 1 |
| Chappelle, MS; Hakim, AA | 1 |
| Andrassy, K; Egbring, R; Egli, H; Krause, W | 1 |
| Dodgson, KS; Jones, JG | 1 |
| Abildgaard, U | 1 |
| Almqvist, S; Pastan, I | 1 |
| Alexander, B; Katchalski, E; Rimon, A | 1 |
| Huseby, RM; Murray, M | 1 |
| York, JL | 1 |
| Derzskaia, SG; Gogolinskaia, GK; Lugovskoĭ, EV | 1 |
| Chen, J; Grabarek, J; Groopman, JE; Herceg-Harjacek, L | 1 |
| Brugge, JS; Cunningham, M; Ginsberg, MH; Haimovich, B; Lipfert, L; Parsons, JT; Shattil, SJ | 1 |
| Abrams, C; Deng, YJ; O'Toole, T; Shattil, SJ; Steiner, B | 1 |
| Brugge, JS; Clark, EA; Markland, FS; Trikha, M | 1 |
| Brugge, JS; Ginsberg, MH; Shattil, SJ | 1 |
| Kunicki, T; Pelletier, AJ; Quaranta, V; Ruggeri, ZM | 1 |
| Brugge, JS; Clark, EA | 1 |
| Brugge, JS; Cunningham, M; Ginsberg, MH; Huang, MM; Lipfert, L; Shattil, SJ | 1 |
| Bolen, J; Brugge, JS; Clark, EA; Ginsberg, MH; Shattil, SJ | 1 |
| Da Silva, ML; McBroom, T; Rice, KG; Tamura, T | 1 |
| Carteaux, JP; Colombo, V; Hadváry, P; Kuhn, H; Roux, S; Tschopp, T | 1 |
| Grütter, MG; Priestle, JP; Rahuel, J; Rink, H; Tones, M | 1 |
| Brugge, JS; Haimovich, B; Lipfert, L; Shattil, SJ | 1 |
| Haimovich, B; Ji, P; Kaneshiki, N | 1 |
| Kamiyama, T; Katoh, H; Nakamura, Y; Satoh, T; Uemura, F; Umino, T; Yokose, K | 1 |
| Miyakawa, Y; Oda, A | 1 |
| Artçanuthurry, V; Grelac, F; Lévy-Tolédano, S; Maclouf, J; Mauco, G; Pidard, D | 1 |
| Fujita, S; Hato, T; Ikeda, Y; Kume, S; Minamoto, Y; Nakatani, S; Oda, A; Ozaki, Y; Watanabe, A | 1 |
| Edwards, BF; Guzik, JC; Malkowski, MG; Martin, PD | 1 |
| Boquet, P; Defilippi, P; Duperray, A; Fiorentini, C; Gulino, D; Palmieri, M; Silengo, L; Tarone, G; Venturino, M; Volpe, G | 1 |
| Akkerman, JW; Donath, J; Hers, I; van Willigen, G | 1 |
| Holmsen, H; Ryningen, A | 1 |
| Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y | 1 |
| Becker, BF; Heindl, B; Welsch, U; Zahler, S | 1 |
| Bansal, V; Detmers, PA; Hanlon, WA; Polizzi, E; Thieringer, R; Vaidya, S; Zhou, D | 1 |
| Lord, ST; Mullin, JL; Rooney, MM | 1 |
| Clunn, GF; Hughes, AD; Lymn, JS; Xie, L | 1 |
| Haimovich, B; Moussazadeh, M | 1 |
| Frojmovic, M; Théroux, P; Xiao, Z | 1 |
| D'Souza, SE; Gardiner, EE | 1 |
| Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM | 1 |
| Holmes, MB; Schneider, DJ; Sobel, BE | 1 |
| Ford, CM; Li, S; Pickering, JG | 1 |
| Peerschke, EI | 1 |
| DeGuzman, FR; Heiser, P; Killeen, N; Law, DA; Ministri-Madrid, K; Phillips, DR | 1 |
| Choi, I; Finkel, B; Foust, RF; Gole, MD; Hertkorn, C; Ischiropoulos, H; Lanken, PN; Malcolm, S; Souza, JM | 1 |
| Chen, Y; D'Souza, SE; Pluskota, E | 1 |
| Harley, SL; Powell, JT | 1 |
| Brown, EB; Frojmovic, MM; Liu, Q; Sloan, SM | 1 |
| De Nardin, E; Hishita, T; Lala, A; Miura, Y; Tohyama, K; Tohyama, Y; Uchiyama, T; Yamamura, H; Yoshida, Y | 1 |
| Bozarth, JM; Forsythe, MS; Mousa, SA; Slee, A | 1 |
| Bachelot-Loza, C; Rendu, F; Saci, A | 1 |
| Judd, BA; Koretzky, GA; Leng, L; Myung, PS; Obergfell, A; Pear, WS; Shattil, SJ | 1 |
| Bonnefoy, A; Frojmovic, MM; Hantgan, R; Legrand, C | 1 |
| Honda, S; Kashiwagi, H; Kiyoi, T; Kosugi, S; Kurata, Y; Matsuzawa, Y; Pampori, N; Shattil, SJ; Tadokoro, S; Tomiyama, Y | 1 |
| Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
| Clemetson, JM; Clemetson, KJ; Dörmann, D; Navdaev, A | 1 |
| Holmes, MB; Kabbani, SS; Schneider, DJ; Sobel, BE; Terrien, CM; Watkins, MW | 1 |
| Lipinski, B | 1 |
| Coller, BS; Jirousková, M | 1 |
| Becker, RC; Li, YF; Spencer, FA | 2 |
| Schrör, K; Weber, AA | 1 |
| Breddin, HK; Esslinger, HU; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Westrup, D | 1 |
| Naor, R; Rosen, G; Sela, MN; Shoshani, M | 1 |
| Kasirer-Friede, A; Leng, L; Marchese, P; Ruggeri, ZM; Shattil, SJ; Ware, J | 1 |
| Aggarwal, A; DiBattiste, PM; Kabbani, SS; Schneider, DJ; Sobel, BE; Terrien, EF | 1 |
| Jacobs, C; Kelm, M; Meila, D; Scharf, RE; Schrör, K; Strauer, BE; Weber, AA; Weber, S; Zotz, RB | 1 |
| Carson, M; Chen, W; Deivanayagam, CC; Höök, M; Narayana, SV; Rajashankar, KR; Wann, ER | 1 |
| Cristofaro, RD; Crocchiolo, R; Landolfi, R; Renda, G; Rocca, B | 1 |
| Frampton, J; Inoue, O; Suzuki-Inoue, K; Watson, SP | 1 |
| Farrell, DH; Lovely, RS; Moaddel, M | 1 |
| ANDREOTTI, L; BENCINI, A | 1 |
| DODGSON, KS; JONES, JG; POWELL, GM; ROSE, FA | 1 |
| COYNE, R; KAPOOR, R; POLLARA, B; RUNQUIST, J; VONKORFF, RW | 1 |
| JEVONS, FR | 1 |
| MACKAY, M | 1 |
| COOKE, JP; MIHALYI, E; SMALL, PA | 1 |
| COOK, MA; HOWELL, RM; SCOTT, GB | 1 |
| Akkerman, JW; Gorter, G; Litjens, PE; van Willigen, G; Ylänne, J | 1 |
| Dubois, C; Reigner, SC; Riederer, MA; Steiner, B | 1 |
| Abrams, CS; Cines, DB | 1 |
| Dale, GL; Hamilton, SF; Miller, MW; Thompson, CA | 1 |
| Anderson, KE; Hibbs, ML; Jackson, SP; Maxwell, MJ; Salem, HH; Yuan, Y | 1 |
| Bredetean, O; Garcia, A; Kunapuli, SP; Meshki, J; Tuluc, F | 1 |
| Akbulut, M; Arslan, N; Dagli, N; Durukan, P; Gundogdu, O; Ilkay, E; Ozbay, Y | 1 |
| Brennan, SO; Dear, A; Dempfle, CE; George, PM; Kirschstein, W | 1 |
| Kołodziejczyk, J; Nowak, P; Wachowicz, B | 1 |
| Billingsley, JM; Fleming, T; Jouvin, MH; Kinet, JP; Kraft, S; Lin, SY; Storz, P | 1 |
| Israels, SJ; McMillan-Ward, EM | 1 |
| Bray, PF; Ito, M; Liu, Y; Sun, W; Vijayan, KV | 1 |
| Honda, S; Honma, N; Kashiwagi, H; Kato, H; Kurata, Y; Shiraga, M; Tomiyama, Y; Yoshida, H | 1 |
| Baumann, PQ; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
| Mazurov, AV; Naimushin, YA | 1 |
| Bucha, E; Nowak, G; Schumann, A | 1 |
| Amano, Y; Matsubayashi, Y; Sakagami, Y; Shinohara, H | 1 |
| Frojmovic, M; Labarthe, B; Legrand, C | 1 |
| Baumann, PQ; Keating, FK; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
| Altman, A; de Virgilio, M; Eto, K; Kawakami, T; Lowell, C; Moran, B; Shattil, SJ; Soriani, A | 1 |
| Antunes, E; Cardoso, MH; De Nucci, G; Lilla, S; Marcondes, S; Morganti, RP; Murad, F; Thomazzi, SM | 1 |
| Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J | 1 |
| Connor, JH; Connor, RF; Hantgan, RR; Mousa, SA; Stahle, MC | 1 |
| Bolikal, D; Kohn, J; Pesnell, A; Weber, N; Zeltinger, J | 1 |
| Graham, AM; Homer-Vanniasinkam, S; Naseem, KM; Oberprieler, NG; Roberts, W | 1 |
| Graham, AM; Homer-Vanniasinkam, S; Naseem, KM; Oberprieler, NG; Riba, R; Roberts, W | 1 |
| Peluffo, G; Radi, R | 1 |
| Dennehy, MK; Fries, DM; Fu, X; Hazen, SL; Heijnen, HF; Ischiropoulos, H; Liebler, DC; Moore, RE; Parastatidis, I; Rader, DJ; Thomson, L; Tohyama, J | 1 |
| Doolittle, RF; Pandi, L | 1 |
| Blue, R; Coller, BS; Jirousková, M; Karan, C; Murcia, M | 1 |
| Chen, P; Liu, JN; Lu, W; Sun, CX | 1 |
| Dietz, K; Peter, K; Schiebold, D; Schoenwaelder, SM; Straub, A; Wendel, HP; Ziemer, G | 1 |
| Jagroop, IA; Mikhailidis, DP | 1 |
| Burke, A; Chernysh, I; Fitzgerald, GA; Heijnen, HF; Ischiropoulos, H; Koliakos, G; Liebler, DC; Nagaswami, C; Parastatidis, I; Stamer, S; Thomson, L; Visser, J; Weisel, JW | 1 |
| Basani, RB; Bennett, JS; Degrado, WF; Kowalska, MA; Poncz, M; Soto, CS; Thornton, MA; Zhu, H | 1 |
| Eriksson, AC; Whiss, PA | 1 |
| Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC | 1 |
| Antunes, E; Cardoso, MH; De Nucci, G; Lilla, S; Marcondes, S; Morganti, RP; Murad, F | 1 |
| Arlaud, GJ; Cesbron, JY; Dumestre-Pérard, C; Gaboriaud, C; Garlatti, V; Gout, E; Lacroix, M; Lunardi, T; Martin, L; Smith, DF; Thielens, NM | 1 |
| Ai, J; Jeon, H; Knight, B; Loch Macdonald, R; Marsden, PA; Sabri, M; Shang, X; Tariq, A | 1 |
| Latour, RA; Sivaraman, B | 1 |
| Andronati, SA; Grygorash, RY; Kabanov, VM; Kabanova, TA; Khristova, TM; Krysko, AA; Krysko, OL; Kuz'min, VE; Polishchuk, PG; Samoylenko, GV; Varnek, AA | 1 |
| Chishti, AH; Herman, IM; Kuchay, SM; Marinkovic, M; Wieschhaus, AJ | 1 |
| Al-Kadhimi, K; Arnould, JC; Barry, ST; Cross, DA; Delouvrié, B; Didelot, M; Gavine, PR; Germain, H; Harris, CS; Hughes, AM; Jude, DA; Kendrew, J; Lambert-van der Brempt, C; Lohmann, JJ; Ménard, M; Mortlock, AA; Pass, M; Rooney, C; Vautier, M; Vincent, JL; Warin, N | 2 |
| Boylan, B; Cooley, BC; Gao, C; Hayes, V; McKenzie, SE; Newman, DK; Newman, PJ; Poncz, M; Rauova, L; Zhi, H | 1 |
| Brennan, SO; Chitlur, M | 1 |
| Fedyanin, AA; Gafarova, MA; Khokhlova, MD; Kryukova, DV; Lyubin, EV; Muravyov, AV; Rikova, SY; Shahnazarov, AA; Skryabina, MN; Sokolova, IA | 1 |
| Ding, Y; Fu, J; Luo, Y | 1 |
| Brodbelt, JS; Moore, KL; Robinson, MR | 1 |
| Badalamenti, S; Clerici, M; Colombo, G; Dalle-Donne, I; Giustarini, D; Milzani, A; Portinaro, N; Rossi, R | 1 |
| Alameda, F; Bosch-Morató, M; Caballo, C; Escolar, G; Galan, AM; Gil-Gómez, G; Guivernau, B; Guix, FX; Ill-Raga, G; Jiménez-Conde, J; Lopez-Vilchez, I; Muñoz, FJ; Ois, A; Opazo, C; Palomer, E; Pérez-Asensio, F; Planas, AM; Ramos-Fernández, E; Reyes-Navarro, M; Roquer, J; Tajes, M; Valls-Comamala, V; Valverde, MA | 1 |
| Aslan, JE; Druker, BJ; Gruber, A; Healy, LD; Loren, CP; McCarty, OJ; Nowak, MS; Rigg, RA | 1 |
| Huang, Q; Ke, Z | 1 |
| Basu, S; Gilmore, AC; Helms, CC; Kapadia, S; Kim-Shapiro, DB; Lu, Z | 1 |
| Altomare, A; Clerici, M; Colombo, G; Dalle-Donne, I; Garavaglia, ML; Giustarini, D; Milzani, A; Portinaro, N; Rossi, R; Rusconi, F | 1 |
| Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Afonso, C; Bonino, L; Borthagaray, G; López, E; Medeiros, R; Pitt, A; Rossi, S; Sousa, B; Spickett, C | 1 |
8 review(s) available for tyrosine and fibrinogen
| Article | Year |
|---|---|
Adhesive signaling in platelets.
Topics: Amino Acid Sequence; Animals; Antigens, CD; Fibrinogen; Humans; Integrin beta1; Integrins; Ligands; Models, Biological; Molecular Sequence Data; Oligopeptides; Phosphotyrosine; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Receptors, Cytoadhesin; Signal Transduction; Tyrosine | 1994 |
[Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple angonists].
Topics: Blood Platelets; Bone Marrow Transplantation; Calcium; Fibrinogen; Humans; Phosphorylation; Platelet Aggregation; Signal Transduction; Stress, Mechanical; Thrombopoietin; Tyrosine | 1996 |
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine | 1999 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS.
Topics: Caseins; Chemistry Techniques, Analytical; Deoxyribonuclease I; Factor XII; Fibrinogen; Fibrinolysin; Glycerol; Humans; Hydrogen-Ion Concentration; Plasminogen; Research; Streptodornase and Streptokinase; Streptokinase; Tyrosine | 1964 |
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Clinical Trials as Topic; Epitopes; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Mice; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombocytopenia; Tirofiban; Tyrosine | 2004 |
Biochemistry of protein tyrosine nitration in cardiovascular pathology.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Fibrinogen; Humans; Nitric Oxide; Nitrosation; Signal Transduction; Superoxide Dismutase; Tyrosine | 2007 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
4 trial(s) available for tyrosine and fibrinogen
| Article | Year |
|---|---|
Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Topics: Aged; Amino Acid Sequence; Angina, Unstable; Blood Platelets; Cell Aggregation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Heparin; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Neutrophils; P-Selectin; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Thrombin; Tirofiban; Tyrosine | 1999 |
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects.
Topics: Adenosine Diphosphate; Adult; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peptides; Platelet Aggregation Inhibitors; Protein Binding; Tirofiban; Tyrosine | 1999 |
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.
Topics: Abciximab; Adolescent; Adult; Antibodies, Monoclonal; Anticoagulants; Binding, Competitive; Bleeding Time; Blood Platelets; Drug Interactions; Factor Xa Inhibitors; Fibrinogen; Flow Cytometry; Heparin; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Selectins; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
182 other study(ies) available for tyrosine and fibrinogen
| Article | Year |
|---|---|
Fluorescence of proteins in aqueous neutral salt solutions. II. Influence of monovalent cation chlorides, particularly cesium chloride.
Topics: Cations, Monovalent; Cesium; Chlorides; Fibrinogen; Fructose-Bisphosphate Aldolase; Hydrogen-Ion Concentration; Muramidase; Ovalbumin; Proteins; Ribonucleases; Serum Albumin, Bovine; Spectrometry, Fluorescence; Trypsin; Tryptophan; Tyrosine | 1977 |
Effect of specific antibodies and a2-macroglobulin on emzymatic activity of trypsin and chymotrypsin.
Topics: Alpha-Globulins; Anilides; Animals; Antibodies; Antigen-Antibody Complex; Blood Coagulation; Chymotrypsin; Collagen; Cross Reactions; Fibrinogen; gamma-Globulins; Immunodiffusion; Macroglobulins; Pancreatic Elastase; Precipitin Tests; Rabbits; Trypsin; Tyrosine | 1975 |
Cationic proteins of human granulocytes. IV. Esterase activity.
Topics: Arginine; Benzamides; Caseins; Esterases; Esters; Fibrinogen; Granulocytes; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ions; Leukocytes; Molecular Weight; Phagocytosis; Proteins; Staphylococcus; Tosyl Compounds; Tyrosine | 1975 |
Radioiodinated human fibrinogen. In vitro effects of increasing iodination.
Topics: Amino Acids; Blood Coagulation; Cell Aggregation; Chromatography, Agarose; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Glycine; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Iodine; Iodine Isotopes; Isoelectric Focusing; Peptides; Prothrombin Time; Tyrosine | 1975 |
Characterization of the amino acids of bovine fibrinogen involved in the fibrinogen-thrombin interaction of the blood clotting process. Comparison with the milk clotting process.
Topics: Amino Acid Sequence; Animals; Blood Coagulation; Caseins; Cattle; Chemical Phenomena; Chemistry; Chymosin; Female; Fibrinogen; Histidine; Hydrolysis; Indicators and Reagents; Methionine; Photochemistry; Protein Conformation; Thrombin; Tryptophan; Tyrosine | 1978 |
The sites of the lactoperoxidase-catalyzed iodination of human fibrinogen.
Topics: Amino Acid Sequence; Binding Sites; Fibrinogen; Humans; Iodine Radioisotopes; Lactoperoxidase; Peptide Fragments; Peroxidases; Tyrosine | 1979 |
Four states of tyrosine residues in the fibrinogen molecule.
Topics: Fibrinogen; Guanidines; Humans; Isoelectric Point; Peptide Fragments; Protein Denaturation; Spectrophotometry, Ultraviolet; Tyrosine | 1978 |
Fluorescence of proteins in aqueous neutral salt solutions. I. Influence of anions.
Topics: Anions; Chemical Phenomena; Chemistry; Fibrinogen; Mathematics; Methods; Muramidase; Papain; Proteins; Ribonucleases; Serum Albumin, Bovine; Spectrometry, Fluorescence; Trypsin; Tryptophan; Tyrosine | 1977 |
Coagulation studies during therapeutic application of arvin.
Topics: Afibrinogenemia; Ancrod; Batroxobin; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Platelets; Drug Resistance; Endopeptidases; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Injections, Subcutaneous; Platelet Aggregation; Thrombin; Thrombocytopenia; Tyrosine | 1976 |
Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.
Topics: Animals; Arsenicals; Azo Compounds; Basophils; Benzene Derivatives; Blood Coagulation Factors; Capillary Permeability; Dinitrochlorobenzene; Ear; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Guinea Pigs; Hemocyanins; Humans; Hypersensitivity, Delayed; Male; Mycobacterium; Ovalbumin; Serum Albumin, Radio-Iodinated; Tuberculin Test; Tyrosine; Warfarin | 1975 |
Estrogen induced appearance of N-terminal glycine from chromatographically purified fibrinogen.
Topics: Alanine; Chromatography, Thin Layer; Estrogens; Fibrinogen; Glycine; Humans; Tyrosine | 1975 |
Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A.
Topics: Amino Acid Sequence; Amino Acids; Animals; Binding Sites; Fibrinogen; Humans; Immune Sera; Iodine Radioisotopes; Isotope Labeling; Peptides; Rabbits; Radioimmunoassay; Streptokinase; Tyrosine; Ultrafiltration | 1975 |
Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
Topics: Arginine; Benzoylarginine Nitroanilide; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Hydroxylamines; Imidazoles; Phenylacetates; Phenylmethylsulfonyl Fluoride; Structure-Activity Relationship; Thrombin; Tosyllysine Chloromethyl Ketone; Tyrosine | 1975 |
Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
Topics: Amino Acid Sequence; Batroxobin; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Protein Binding; Radioimmunoassay; Retinal Diseases; Retinal Vessels; Thrombophlebitis; Thrombosis; Tyrosine | 1975 |
The involvement of aromatic amino acids in biological activity of bovine fibrinogen as assessed by gamma-irradiation.
Topics: Amino Acids; Blood Coagulation; Fibrinogen; Free Radicals; Gamma Rays; Nitrates; Potassium Iodide; Radiation Effects; Radiation-Protective Agents; Radiation-Sensitizing Agents; Sodium; Tryptophan; Tyrosine | 1976 |
Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets.
Topics: Blood Platelets; Cell Adhesion Molecules; Collagen; Cytochalasin D; Enzyme Activation; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Phosphorylation; Phosphotyrosine; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Thrombin; Tyrosine | 1992 |
Signal transduction by the platelet integrin alpha IIb beta 3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells.
Topics: Blood Platelets; Calcium; Cell Adhesion; Cell Line; Cell Size; Fibrinogen; Integrins; Periodicity; Phosphorylation; Signal Transduction; Transfection; Tyrosine | 1992 |
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Binding Sites; Endothelium, Vascular; Fibrinogen; Humans; Molecular Sequence Data; Molecular Structure; Oligopeptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Tirofiban; Tyrosine; Umbilical Veins | 1992 |
Photoaffinity labeling of the primary fibrin polymerization site: localization of the label to gamma-chain Tyr-363.
Topics: Affinity Labels; Amino Acid Sequence; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Models, Molecular; Molecular Sequence Data; Photochemistry; Polymers; Tyrosine | 1992 |
Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins.
Topics: Antibodies, Monoclonal; Blood Platelets; Blood Proteins; Enzyme Activation; Fibrinogen; Humans; Immunoblotting; Molecular Weight; Phosphoproteins; Phosphorylation; Phosphotyrosine; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Conformation; Protein-Tyrosine Kinases; Tyrosine | 1990 |
Recombinant human fibrinogen and sulfation of the gamma' chain.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cell Line; Cloning, Molecular; Cricetinae; Fibrinogen; Genetic Vectors; Humans; Molecular Sequence Data; Molecular Weight; Oligonucleotides; Recombinant Proteins; Sulfates; Tyrosine | 1991 |
Identification of complexes between the tyrosine-O-sulphate-binding protein and tyrosine-sulphated proteins in bovine liver membrane lysates.
Topics: Animals; Blotting, Western; Carrier Proteins; Cattle; Cell Membrane; Complement C4; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibronectins; Immunosorbent Techniques; Intercellular Signaling Peptides and Proteins; Liver; Membrane Proteins; Molecular Weight; Tyrosine | 1991 |
Tyrosine sulfation of proteins from the human hepatoma cell line HepG2.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell Line; Chromatography, Thin Layer; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Processing, Post-Translational; Tyrosine | 1985 |
Sulfation of a gamma-chain variant of human fibrinogen.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; Chromatography, Ion Exchange; Fibrinogen; Humans; Liver Neoplasms; Molecular Sequence Data; Precipitin Tests; Sequence Homology, Nucleic Acid; Sulfates; Tumor Cells, Cultured; Tyrosine | 1989 |
Identification and assay of phosphoserine and tyrosine-O-sulphate in fibrinopeptides by reversed-phase high-performance liquid chromatography.
Topics: Amino Acids; Chromatography, High Pressure Liquid; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Hydrolysis; Phosphates; Phosphoserine; Serine; Tyrosine | 1986 |
Tyrosine O-sulfation of the fibrinogen gamma B chain in primary cultures of rat hepatocytes.
Topics: Animals; Cells, Cultured; Fibrinogen; Hydrogen-Ion Concentration; Kinetics; Liver; Macromolecular Substances; Male; Rats; Rats, Inbred Strains; Sulfates; Sulfur Radioisotopes; Tyrosine | 1988 |
Identification of tyrosine O-sulfate in proteins by reverse-phase high-performance liquid chromatography: use of base hydrolysis combined with precolumn derivatization using phenyl isothiocyanate.
Topics: Animals; Barium; Barium Compounds; Cattle; Chromatography, High Pressure Liquid; Fibrinogen; Hydrolysis; Isothiocyanates; Proteins; Thiocyanates; Tyrosine | 1986 |
Molecular aspects of the clottable proteins of human plasma during fibrinogenolysis.
Topics: Alanine; Blood Coagulation; Blood Coagulation Tests; Blood Protein Electrophoresis; Blood Proteins; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Glycine; Humans; Molecular Weight; Tyrosine; Urokinase-Type Plasminogen Activator | 1974 |
Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen.
Topics: Calcium; Electrophoresis, Polyacrylamide Gel; Factor XIII; Fibrinogen; Glycine; Hirudins; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Iodine Isotopes; Molecular Conformation; Peptide Fragments; Radiometry; Scintillation Counting; Solubility; Thrombin; Tyrosine | 1974 |
Lamprey fibrinopeptide B is a glycopeptide.
Topics: Animals; Carbohydrates; Cattle; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis; Fibrinogen; Fishes; Glucosamine; Glycopeptides; Humans; Lampreys; Molecular Weight; Peptide Fragments; Sialic Acids; Species Specificity; Sulfuric Acid Esters; Tyrosine | 1974 |
The quenching of the tryptophyl and tyrosyl fluorescence of proteins by cesium ion.
Topics: Cesium; Chlorides; Fibrinogen; Iodides; Muramidase; Osmolar Concentration; Potassium; Potassium Chloride; Protein Binding; Proteins; Ribonucleases; Serum Albumin; Spectrometry, Fluorescence; Tryptophan; Tyrosine | 1974 |
[Spectrophotometric determination of the tyrosine and tryptophan content of bovine fibrinogen].
Topics: Animals; Cattle; Fibrinogen; Guanidines; Hydrogen-Ion Concentration; Methods; Potassium Chloride; Spectrophotometry; Tryptophan; Tyrosine | 1972 |
[Characteristics of the chemical structure of chick fibrinogen].
Topics: Animals; Blood Coagulation; Chickens; Fibrinogen; Glycopeptides; Hexosamines; Hexoses; Neuraminic Acids; Spectrophotometry, Ultraviolet; Tryptophan; Tyrosine | 1972 |
Comparison of rapid clottable fibrinogen assays.
Topics: Blood Coagulation; Densitometry; Fibrinogen; Humans; Hydrolysis; Mathematics; Methods; Sodium Hydroxide; Thrombin; Tyrosine | 1972 |
Studies of radioiodinated fibrinogen. I. Physicochemical properties of the ICl, chloramine-T, and electrolytic reaction products.
Topics: Animals; Chloramines; Chlorides; Chromatography, Gel; Dogs; Electrolysis; Fibrinogen; Humans; Hydrolysis; Iodides; Iodine; Iodine Isotopes; Isotope Labeling; Kinetics; Molecular Weight; Sodium; Spectrophotometry, Ultraviolet; Tyrosine | 1972 |
Studies on soluble fibrin in plasma. 3. N-terminal analysis of a modified fraction I (Cohn) from plasmin- and thrombin-incubated plasma.
Topics: Alanine; Aspartic Acid; Autoanalysis; Blood Coagulation; Blood Proteins; Buffers; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Glutamates; Glycine; Humans; Methods; Solubility; Thrombin; Tyrosine | 1973 |
On the reaction of purified bovine thrombin with N-acetylimidazole.
Topics: Acetates; Acetylation; Animals; Arginine; Binding Sites; Binding, Competitive; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Drug Stability; Enzyme Activation; Esterases; Esters; Fibrinogen; Hydrogen-Ion Concentration; Imidazoles; Protein Conformation; Spectrophotometry; Structure-Activity Relationship; Thrombin; Time Factors; Tosyl Compounds; Tyrosine | 1973 |
Bovine fibrinogen. II. Effects of tyrosine modification on fibrin monomer aggregation.
Topics: Acetylation; Amidines; Animals; Blood Coagulation Tests; Cattle; Chemical Phenomena; Chemistry; Fibrin; Fibrinogen; Kinetics; Lysine; Protein Conformation; Protein Denaturation; Tyrosine; Urea | 1973 |
Preferential syntheisi of thyroxine from early iodinated tyrosyl residues in thyroglobulin.
Topics: Amino Acids; Caseins; Chemical Phenomena; Chemistry; Chromatography, Paper; Dialysis; Diiodotyrosine; Fibrinogen; Glucose Oxidase; Goiter, Nodular; Humans; Iodine; Iodine Radioisotopes; Isotope Labeling; Monoiodotyrosine; Peroxidases; Pronase; Structure-Activity Relationship; Thyroglobulin; Thyroid Gland; Thyroxine; Tyrosine | 1974 |
Interaction between red cell membranes and fibrinogen.
Topics: Alanine; Amino Acids; Aspartic Acid; Blood Coagulation Tests; Cell Membrane; Erythrocytes; Fibrin; Fibrinogen; Glycine; Humans; Protein Conformation; Tyrosine | 1974 |
The quantitation of isotope loss with tyrosine loss in the canine fibrinogen-fibrin transformation.
Topics: Animals; Blood Coagulation Tests; Chemical Precipitation; Colorimetry; Dogs; Fibrin; Fibrinogen; Iodine Isotopes; Methods; Optics and Photonics; Radioisotope Dilution Technique; Thrombin; Tyrosine; Ultraviolet Rays | 1971 |
Effects of clotting on the label in iodinated fibrinogen in different species.
Topics: Animals; Blood Coagulation; Cattle; Dogs; Fibrin; Fibrinogen; Goats; Guinea Pigs; Haplorhini; Humans; Iodine Isotopes; Peptides; Rabbits; Sheep; Species Specificity; Thrombin; Tyrosine | 1967 |
Effects of testosteronereatment on plasma proteins and amino acids in men.
Topics: 17-Hydroxycorticosteroids; Adult; Amino Acids; Blood Protein Electrophoresis; Blood Proteins; Ceruloplasmin; Depression, Chemical; Fibrinogen; Glutamates; Haptoglobins; Humans; Hydrocortisone; Immunoglobulin G; Male; Proline; Protein Binding; Serum Albumin; Stimulation, Chemical; Testosterone; Thyroxine-Binding Proteins; Transferrin; Trypsin Inhibitors; Tyrosine | 1969 |
Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Binding Sites; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Edetic Acid; Fibrin; Fibrinogen; Glycine; Humans; Immunoelectrophoresis; Models, Biological; Thrombin; Thrombosis; Tyrosine | 1970 |
Studies on soluble fibrin in plasma. I a. N-terminal analysis of a modified fraction I (Cohn) from plasma containing fibrinolytic inhibitors, and incubated with plasminogen-free human thrombin.
Topics: Alanine; Antifibrinolytic Agents; Aspartic Acid; Blood Coagulation; Blood Proteins; Chemical Precipitation; Ethanol; Fibrin; Fibrinogen; Glutamine; Glycine; Humans; In Vitro Techniques; Plasma; Thrombin; Tyrosine | 1972 |
Fibrinaemia and multiple thrombi in pancreatic carcinoma. A case studied with quantitative N-terminal analysis.
Topics: Alanine; Blood Coagulation; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Glycine; Heparin; Humans; Male; Methods; Middle Aged; Pancreatic Neoplasms; Thrombin; Thrombophlebitis; Tyrosine; Warfarin | 1972 |
The differential effect of tetranitromethane on the proteinase and esterase activity of bovine thrombin.
Topics: Amidines; Amino Acids; Animals; Binding Sites; Cattle; Chemical Phenomena; Chemistry; Esterases; Fibrinogen; Methane; Nitro Compounds; Protease Inhibitors; Protein Conformation; Structure-Activity Relationship; Thrombin; Tyrosine | 1971 |
A comparison of blood trauma by various extracorporeal oxygenators.
Topics: Blood; Blood Chemical Analysis; Blood Platelets; Extracorporeal Circulation; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Microscopy, Phase-Contrast; Oximetry; Oxygen; Tyrosine | 1967 |
Bovine fibrinogen--heterogeneity of the gamma-chains.
Topics: Amino Acids; Animals; Blood Protein Electrophoresis; Carbohydrates; Cattle; Chromatography, Ion Exchange; Copper; Fibrinogen; Methods; Molecular Weight; Peptides; Sulfites; Tyrosine; Ultracentrifugation | 1969 |
[Effect of temperature on the structure of fibrinogen].
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Chemistry Techniques, Analytical; Fibrinogen; Light; Molecular Weight; Rotation; Spectrophotometry; Temperature; Tryptophan; Tyrosine; Ultracentrifugation; Ultraviolet Rays | 1970 |
A comparative study of human, cow, pig and sheep fibrinogen.
Topics: Alanine; Amino Acids; Animals; Cattle; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Electrophoresis; Fibrinogen; Glutamates; Humans; Macromolecular Substances; Paper; Peptides; Sheep; Species Specificity; Sulfites; Swine; Thrombin; Trypsin; Tyrosine | 1971 |
Studies on synthetic polypeptide antigens. XX. Genetic control of the antibody response in the rat to structurally different synthetic polypeptide antigens.
Topics: Animals; Antibody Formation; Antigen-Antibody Reactions; Antigens; Chemical Phenomena; Chemistry; Fibrinogen; Glutamine; Haptens; Hemagglutination Tests; Lysine; Molecular Biology; Molecular Weight; Peptides; Radioisotopes; Rats; Serum Albumin, Bovine; Species Specificity; Tyrosine | 1968 |
Physicochemical studies of bovine fibrinogen. IV. Ultraviolet absorption and its relation to the structure of the molecule.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Fibrinogen; Glycols; Guanidines; Hydrogen-Ion Concentration; Protein Denaturation; Solvents; Spectrophotometry; Tryptophan; Tyrosine; Ultraviolet Rays; Urea | 1968 |
The free and buried tyrosyl and histidyl groups in bovine fibrinogen.
Topics: Animals; Azoles; Cattle; Diazonium Compounds; Fibrinogen; Histidine; Imidazoles; Osmolar Concentration; Tyrosine; Urea | 1969 |
Effects on blood clotting and circulation of autologous connective tissue homogenate infusion in dogs.
Topics: Animals; Bicarbonates; Blood Circulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Pressure; Carbon Dioxide; Collagen; Connective Tissue; Dogs; Erythrocyte Count; Factor V; Factor VII; Factor VIII; Factor X; Fibrinogen; Hematocrit; Hemoglobinometry; Hydrogen-Ion Concentration; Infusions, Parenteral; Plasminogen; Proteins; Prothrombin; Tyrosine | 1969 |
Partial chemical characterization of the isolated gamma-chain of human fibrinogen.
Topics: Amino Acid Sequence; Amino Acids; Blood Protein Electrophoresis; Carbohydrates; Carbon Isotopes; Carboxypeptidases; Chromatography, Gel; Chromatography, Ion Exchange; Fibrinogen; Glucosamine; Glycoproteins; Hexoses; Humans; Molecular Weight; Tritium; Trypsin; Tyrosine | 1969 |
Mechanism of action of proteolytic enzymes in the plasminogen-plasmin system.
Topics: Animals; Arginine; Cattle; Chymotrypsin; Esters; Fibrin; Fibrinogen; Hemoglobins; Humans; Plasma; Plasminogen; Spectrophotometry; Streptodornase and Streptokinase; Swine; Time Factors; Trypsin; Tyrosine | 1969 |
[Experiences and modifications for the Seegers method of prothrombin preparation].
Topics: Adsorption; Animals; Anticoagulants; Blood Coagulation Factors; Cattle; Fibrinogen; Globulins; Hydroxides; Magnesium; Prothrombin; Tyrosine | 1969 |
Biosynthesis of L-tyrosine O-sulphate by a novel route.
Topics: Autoradiography; Chromatography, Paper; Electrophoresis; Fibrinogen; In Vitro Techniques; Liver; Subcellular Fractions; Sulfates; Sulfur Isotopes; Tyrosine | 1964 |
N-terminal analysis during coagulation of purified human fibrinogen, fraction I, and plasma.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Blood; Blood Proteins; Cattle; Chemistry Techniques, Analytical; Fibrinogen; Glutamine; Glycine; Humans; In Vitro Techniques; Peptides; Plasma; Thrombin; Tyrosine; Valine | 1965 |
Purification and properties of a mast cell protease.
Topics: Animals; Centrifugation; Chymotrypsin; Enzymes; Fibrinogen; Hemoglobins; In Vitro Techniques; Isoflurophate; Mast Cells; Peptide Hydrolases; Phenylalanine; Rats; Thyroglobulin; Thyroid Gland; Tyrosine | 1966 |
Action of water-insoluble trypsin derivatives on fibrinogen clottability.
Topics: Anhydrides; Animals; Blood Coagulation; Blood Coagulation Tests; Cattle; Electrophoresis; Ethylenes; Fibrinogen; Leucine; Maleates; Phenylalanine; Polymers; Thrombin; Trypsin; Tyrosine; Ultracentrifugation | 1966 |
Molecular structure of fibrinogen. I. Helical content and the role of the tyrosine moiety in the fibrinogen molecule.
Topics: Amino Acids; Animals; Cattle; Chemical Phenomena; Chemistry, Physical; Fibrinogen; Galactose; Glucosamine; Hydrogen-Ion Concentration; In Vitro Techniques; Mannose; Neuraminic Acids; Protein Denaturation; Spectrophotometry; Tyrosine; Ultraviolet Rays | 1967 |
Comparative study of the iodination of tyrosines in the amino terminal domain of fibrinogen and in N-DSK and fibrin-N-DSK.
Topics: Amino Acid Sequence; Chemical Phenomena; Chemistry; Disulfides; Fibrin; Fibrinogen; Fibrinopeptide A; Humans; In Vitro Techniques; Iodine; Iodine Radioisotopes; Isotope Labeling; Lactoperoxidase; Structure-Activity Relationship; Tyrosine | 1983 |
[Study of fibrinogen-fibrin cryocomplexes by a quantitative analysis of N-terminal amino acids].
Topics: Animals; Cattle; Chromatography, Gel; Cold Temperature; Fibrin; Fibrinogen; Glutamates; Glycine; Macromolecular Substances; Thrombin; Tyrosine; Ultracentrifugation | 1983 |
Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Blood Platelets; Fibrinogen; Humans; In Vitro Techniques; Megakaryocytes; Molecular Sequence Data; Neoplasm Proteins; Oligopeptides; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins; Receptors, Cytokine; Receptors, Immunologic; Receptors, Thrombopoietin; Thrombopoietin; Tyrosine | 1995 |
Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Actins; Alprostadil; Apyrase; Blood Platelets; Calcium; Cell Adhesion Molecules; Cytoplasm; Egtazic Acid; Epinephrine; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Indoles; Indomethacin; Maleimides; Models, Biological; Phosphorylation; Phosphotyrosine; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Thromboxane A2; Tyrosine; Vasodilator Agents | 1994 |
Determinants of specificity of a baculovirus-expressed antibody Fab fragment that binds selectively to the activated form of integrin alpha IIb beta 3.
Topics: Amino Acid Sequence; Animals; Antibody Specificity; Baculoviridae; Binding Sites, Antibody; Blood Platelets; Endothelium, Vascular; Fibrinogen; Immunoglobulin Fab Fragments; In Vitro Techniques; Integrins; Molecular Sequence Data; Moths; Oligopeptides; Phosphotyrosine; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship; Tyrosine | 1994 |
Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation.
Topics: Amino Acid Sequence; Binding Sites; Blood Platelets; Crotalid Venoms; Disintegrins; Fibrinogen; Integrins; Molecular Sequence Data; Peptides; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Signal Transduction; Thrombin; Tyrosine; Viper Venoms | 1994 |
The activation state of the integrin alpha IIb beta 3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation.
Topics: Antibodies, Monoclonal; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Transformed; Cell Movement; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Phosphorylation; Phosphotyrosine; Platelet Glycoprotein GPIIb-IIIa Complex; Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 1995 |
Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets.
Topics: Biological Transport; Cell Compartmentation; Cytoskeleton; Fibrinogen; Humans; Integrins; Octoxynol; Phosphotyrosine; Platelet Activation; Platelet Membrane Glycoproteins; Polyethylene Glycols; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Solubility; Thrombasthenia; Thrombin; Tyrosine | 1993 |
Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK.
Topics: Actins; Amino Acid Sequence; Blood Platelets; Blood Proteins; Cell Adhesion Molecules; Cytochalasin D; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Molecular Sequence Data; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Tyrosine | 1993 |
Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3.
Topics: Blood Platelets; Cytoskeleton; Enzyme Activation; Enzyme Precursors; Fibrinogen; Humans; Integrins; Intracellular Signaling Peptides and Proteins; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Syk Kinase; Thrombin; Tyrosine | 1994 |
Tyrosine derivatization and preparative purification of the sialyl and asialy-N-linked oligosaccharides from porcine fibrinogen.
Topics: Animals; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Fibrinogen; Glycopeptides; Glycoproteins; Magnetic Resonance Spectroscopy; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Molecular Sequence Data; Oligosaccharides; Swine; Tyrosine | 1994 |
Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.
Topics: Acetates; Animals; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonary Bypass; Dogs; Female; Fibrinogen; Hematocrit; Male; Microscopy, Electron, Scanning; Oxygenators, Membrane; Platelet Aggregation; Platelet Count; Platelet Membrane Glycoproteins; Tyrosine | 1993 |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
Topics: Amino Acid Sequence; Binding Sites; Crystallization; Crystallography, X-Ray; Electrochemistry; Fibrinogen; Hirudins; Humans; Hydrogen Bonding; Molecular Sequence Data; Molecular Structure; Protein Conformation; Structure-Activity Relationship; Sulfates; Thrombin; Tyrosine | 1993 |
Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands.
Topics: Blood Platelets; Collagen; Cytoskeleton; Fibrinogen; Humans; In Vitro Techniques; Phosphorylation; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Signal Transduction; Tyrosine | 1993 |
Protein kinase C regulates tyrosine phosphorylation of pp125FAK in platelets adherent to fibrinogen.
Topics: Adenosine Diphosphate; Apyrase; Blood Platelets; Calcium; Cell Adhesion Molecules; Cell Size; Egtazic Acid; Enzyme Inhibitors; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Indoles; Maleimides; Phosphoproteins; Phosphorylation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Signal Transduction; Terpenes; Tetradecanoylphorbol Acetate; Thapsigargin; Tyrosine | 1996 |
Monamidocin, a novel fibrinogen receptor antagonist. II. Biological activity and structure-activity relationships.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Collagen; Fibrinogen; Humans; Molecular Sequence Data; Molecular Structure; Phenylalanine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Streptomyces; Structure-Activity Relationship; Thrombin; Tyrosine | 1995 |
Total inhibition of phospholipase C and phosphatidylinositol 3-kinase by okadaic acid in thrombin-stimulated platelets.
Topics: Blood Platelets; Blood Proteins; Enzyme Inhibitors; Fibrinogen; Humans; Mitogens; Okadaic Acid; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Platelet Glycoprotein GPIIb-IIIa Complex; Precipitin Tests; Thrombin; Type C Phospholipases; Tyrosine | 1997 |
Outside-in signaling from integrin alpha IIb beta 3 into platelets in the absence of agonist-induced signaling.
Topics: Antibodies, Monoclonal; Blood Platelets; Calcium; Cell Adhesion Molecules; Enzyme Precursors; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoglobulin Fab Fragments; Intracellular Signaling Peptides and Proteins; Phosphorylation; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein-Tyrosine Kinases; Signal Transduction; Syk Kinase; Thromboxane B2; Tyrosine | 1997 |
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
Topics: Animals; Binding Sites; Blood Coagulation; Cattle; Crystallography, X-Ray; Enzyme Precursors; Fibrinogen; Humans; Ligands; Molecular Sequence Data; Motion; Proline; Protein Conformation; Prothrombin; Species Specificity; Thrombin; Tryptophan; Tyrosine | 1997 |
Dissection of pathways implicated in integrin-mediated actin cytoskeleton assembly. Involvement of protein kinase C, Rho GTPase, and tyrosine phosphorylation.
Topics: Actins; Animals; Bacterial Toxins; Cell Adhesion; Cell Adhesion Molecules; CHO Cells; Cricetinae; Cytoskeleton; Cytotoxins; Enzyme Activation; Escherichia coli Proteins; Fibrinogen; Fluorescent Antibody Technique, Indirect; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; GTP-Binding Proteins; GTPase-Activating Proteins; Integrins; Mice; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein-Tyrosine Kinases; Rabbits; Receptor, Insulin; Tetradecanoylphorbol Acetate; Transfection; Tyrosine | 1997 |
Differential involvement of tyrosine and serine/threonine kinases in platelet integrin alphaIIbbeta3 exposure.
Topics: Blood Platelets; Enzyme Inhibitors; Fibrinogen; Humans; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Thromboxane A2; Tyrosine | 1998 |
Thrombin per se does not induce tyrosine protein phosphorylation in human platelets as judged by western blotting, while collagen does: the significance of synergistic, autocrine stimulation.
Topics: Autocrine Communication; Blood Platelets; Blotting, Western; Collagen; Drug Synergism; Fibrinogen; Humans; Oligopeptides; Phosphorylation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Thrombin; Tyrosine | 1998 |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine | 1998 |
Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts.
Topics: Acetates; Adult; Analysis of Variance; Animals; Blood Platelets; Cell Degranulation; Coronary Vessels; Endothelium, Vascular; Fibrinogen; Guinea Pigs; Humans; Male; Microscopy, Electron; Myocardial Ischemia; Myocardial Reperfusion; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Tyrosine | 1998 |
Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; CD18 Antigens; Cell Adhesion; Dose-Response Relationship, Immunologic; Enzyme Inhibitors; Fibrinogen; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Respiratory Burst; Stress, Physiological; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine | 1998 |
Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Topics: Amino Acid Substitution; Animals; Catalysis; CHO Cells; Cricetinae; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Hydrolysis; Peptide Fragments; Phenylalanine; Polymers; Recombinant Proteins; Thrombin; Time Factors; Tyrosine | 1998 |
Role of intracellular calcium ([Ca2+]i) and tyrosine phosphorylation in adhesion of cultured vascular smooth muscle cells to fibrinogen.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Adhesion; Cell Line; Cells, Cultured; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Fibrinogen; Genistein; Humans; Integrins; Intracellular Fluid; Muscle, Smooth, Vascular; Nickel; Oligopeptides; Phosphorylation; Protein-Tyrosine Kinases; Rats; Regression Analysis; Tyrosine | 1998 |
Protein kinase C-delta activation and tyrosine phosphorylation in platelets.
Topics: Antibodies, Monoclonal; Blood Platelets; Cell Fractionation; Enzyme Activation; Fibrinogen; Humans; In Vitro Techniques; Isoenzymes; Phosphorylation; Phosphotyrosine; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein Kinase C-delta; Thrombin; Tyrosine | 1998 |
Sequences within fibrinogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis.
Topics: Amino Acid Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Fibrinogen; Intercellular Adhesion Molecule-1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitogens; Molecular Sequence Data; Oncogene Protein pp60(v-src); Phosphorylation; Signal Transduction; Tyrosine | 1999 |
Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation.
Topics: Angiotensin II; Collagen; Enzyme Inhibitors; Fibrinogen; Genistein; Humans; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Tyrosine; Tyrphostins | 1999 |
Maintenance of GPIIb-IIIa avidity supporting "irreversible" fibrinogen binding is energy-dependent.
Topics: Adenosine Diphosphate; Androstadienes; Anti-Bacterial Agents; Antibodies, Monoclonal; Antimetabolites; Antimycin A; Benzoquinones; Blood Platelets; Deoxyglucose; Dimethyl Sulfoxide; Energy Metabolism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Excipients; Fibrinogen; Humans; Lactams, Macrocyclic; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polylysine; Protein Binding; Protein-Tyrosine Kinases; Quinones; Rifabutin; Signal Transduction; Tyrosine; Wortmannin | 1999 |
Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function.
Topics: Amino Acid Motifs; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Cloning, Molecular; Cytoplasm; Fibrinogen; In Vitro Techniques; Mice; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Signal Transduction; Tyrosine | 1999 |
Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome.
Topics: Acute Disease; Adult; alpha 1-Antichymotrypsin; Blood Proteins; Blotting, Western; Carbon Dioxide; Ceruloplasmin; Enzyme Activation; Fibrinogen; Humans; In Vitro Techniques; Nitrates; Nitric Oxide; Oxidative Stress; Precipitin Tests; Respiratory Distress Syndrome; Superoxides; Tyrosine | 2000 |
Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival.
Topics: Amino Acid Motifs; Cell Survival; Cells, Cultured; Endothelium, Vascular; Fibrinogen; Intercellular Adhesion Molecule-1; Intracellular Signaling Peptides and Proteins; Peptide Fragments; Phosphopeptides; Phosphoproteins; Phosphorylation; Protein Binding; Protein Phosphatase 2; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Receptors, Immunologic; SH2 Domain-Containing Protein Tyrosine Phosphatases; src Homology Domains; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |
Interaction of fibrinogen with saphenous vein endothelial cells stimulates tyrosine phosphorylation of cortactin.
Topics: Cells, Cultured; Cortactin; Endothelium, Vascular; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Microfilament Proteins; Phosphorylation; Saphenous Vein; Signal Transduction; Tyrosine | 2000 |
Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
Topics: Acetates; Antibodies, Monoclonal; Binding Sites; Blood Platelets; Calcium; Cell Size; Fibrinogen; Flow Cytometry; Humans; Kinetics; Liposomes; Microspheres; Models, Chemical; Particle Size; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Precipitin Tests; Protein Binding; Receptors, Cell Surface; Tyrosine | 2000 |
Pyk2 and Syk participate in functional activation of granulocytic HL-60 cells in a different manner.
Topics: CD18 Antigens; Cell Adhesion; Cell Differentiation; Enzyme Precursors; Fibrinogen; Focal Adhesion Kinase 2; Granulocytes; HL-60 Cells; Humans; Intracellular Signaling Peptides and Proteins; N-Formylmethionine Leucyl-Phenylalanine; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Syk Kinase; Tyrosine | 2000 |
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.
Topics: Abciximab; Alanine; Amidines; Analysis of Variance; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Calcium; Citric Acid; Eptifibatide; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Isoxazoles; Peptides; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyrrolidines; Tirofiban; Tyrosine | 2000 |
Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.
Topics: Actins; Blood Platelets; Enzyme Precursors; Fibrinogen; Humans; Intracellular Signaling Peptides and Proteins; Oncogene Protein v-cbl; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein-Tyrosine Kinases; Retroviridae Proteins, Oncogenic; src-Family Kinases; Syk Kinase; Tyrosine | 2000 |
Hematopoietic reconstitution of SLP-76 corrects hemostasis and platelet signaling through alpha IIb beta 3 and collagen receptors.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Platelets; Fibrinogen; Hematopoiesis; Hemostasis; Humans; Integrins; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phosphoproteins; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Collagen; Signal Transduction; Tyrosine | 2000 |
A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor.
Topics: Acetates; Blood Platelets; Fibrinogen; Flow Injection Analysis; Models, Biological; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Binding; Thrombospondin 1; Thrombospondins; Tyrosine | 2001 |
Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit.
Topics: Amino Acid Sequence; Binding Sites; Cell Adhesion; Cell Line; Epitopes; Fibrinogen; Gene Expression; Humans; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Structure, Tertiary; Protein Subunits; Receptors, Vitronectin; Recombinant Proteins; Transfection; Tyrosine | 2001 |
Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction.
Topics: Acetates; Animals; Aspirin; Avidin; Binding Sites; Biotinylation; Blood Proteins; Carrier Proteins; Chelating Agents; Edetic Acid; Fibrinogen; Immunoglobulin kappa-Chains; Immunoglobulin M; Lectins; Macromolecular Substances; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proteins; Signal Transduction; Tyrosine; Viper Venoms | 2001 |
Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine | 2001 |
Dityrosine crosslinking of fibrin(ogen) may offer additional protection of tumor cells against immune killing.
Topics: Cell Membrane; Cross-Linking Reagents; Fibrinogen; Humans; Immune System; Killer Cells, Lymphokine-Activated; Tumor Cells, Cultured; Tyrosine | 2001 |
Platelet adhesion to fibrinogen coated at various densities.
Topics: Blood Platelets; Cell Adhesion; Fibrinogen; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Tyrosine | 2001 |
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition.
Topics: Adult; Cells, Cultured; Dose-Response Relationship, Drug; Eptifibatide; Fibrinogen; Humans; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Reference Values; Tirofiban; Tyrosine | 2001 |
Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Biotinylation; Depression, Chemical; Dose-Response Relationship, Drug; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Kinetics; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Proteins; Receptors, Thrombin; Tirofiban; Tyrosine | 2001 |
The purification and characterization of an 88-kDa Porphyromonas endodontalis 35406 protease.
Topics: Aminopeptidases; Angiotensins; Bradykinin; Chromogenic Compounds; Collagen Type IV; Cystinyl Aminopeptidase; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Fibrinogen; Fibronectins; Hot Temperature; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Lysine Carboxypeptidase; Molecular Weight; Oxidants; Oxidation-Reduction; Phenylalanine; Porphyromonas; Sodium Dodecyl Sulfate; Surface-Active Agents; Temperature; Tyrosine; Vasopressins | 2001 |
Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIbbeta 3.
Topics: Animals; Blood Platelets; Cell Adhesion; Cells, Cultured; CHO Cells; Cricetinae; Dimerization; Dose-Response Relationship, Drug; Fibrinogen; Humans; Phosphorylation; Plasmids; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Signal Transduction; Spectrometry, Fluorescence; Transfection; Tyrosine; Up-Regulation; von Willebrand Factor | 2002 |
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Coagulation Tests; Coronary Disease; Drug Therapy, Combination; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine | 2002 |
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
Topics: Adult; Blood Platelets; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Humans; Linear Models; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2002 |
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Antigens, Human Platelet; Blood Platelets; Fibrinogen; Genotype; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Tirofiban; Tyrosine | 2002 |
A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A.
Topics: Adhesins, Bacterial; Amino Acid Sequence; Binding Sites; Circular Dichroism; Crystallography, X-Ray; DNA Mutational Analysis; Dose-Response Relationship, Drug; Fibrinogen; Immunoglobulins; Lysine; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutagenesis, Site-Directed; Proline; Protein Binding; Protein Conformation; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid; Staphylococcus aureus; Tyrosine | 2002 |
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Binding, Competitive; Dose-Response Relationship, Drug; Female; Fibrinogen; Fibrinolytic Agents; Genetic Variation; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Tirofiban; Tyrosine; von Willebrand Factor | 2003 |
Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
Topics: Animals; Blood Platelets; Collagen; Crotalid Venoms; Enzyme Inhibitors; Fibrinogen; Humans; Integrin alpha2beta1; Lectins, C-Type; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phospholipase C gamma; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Receptors, Fc; src-Family Kinases; Type C Phospholipases; Tyrosine | 2003 |
Fibrinogen gamma' chain binds thrombin exosite II.
Topics: Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Cell Line; DNA; Fibrinogen; Heparin; Hirudins; Humans; Kinetics; Mice; Molecular Sequence Data; Protein Binding; Protein Isoforms; Recombinant Proteins; Substrate Specificity; Thrombin; Transfection; Tyrosine | 2003 |
[Qualitative changes in fibrinogen in pathological conditions; the carbohydrate content of fibrinogen; preliminary note].
Topics: Biochemical Phenomena; Carbohydrate Metabolism; Carbohydrates; Coagulants; Fibrinogen; Hemostatics; Humans; Tyrosine | 1958 |
Studies on L-tyrosine O-sulphate. 3. The metabolic fate of the L-tyrosine O[35S]-sulphate residue of 35S-labelled rabbit fibrinopeptide B.
Topics: Animals; Fibrinogen; Fibrinopeptide B; Phenylacetates; Phenylurea Compounds; Rabbits; Sulfates; Tyrosine | 1963 |
APPLICATION OF RADIOISOTOPIC YIELD TO THE QUANTITATION OF THE N-TERMINAL AMINO ACIDS OF FIBRINOGEN.
Topics: Amino Acids; Animals; Aspartic Acid; Carbon Isotopes; Cattle; Chromatography; Fibrinogen; Glutamates; Glycine; Hydantoins; Research; Tyrosine | 1963 |
TYROSINE O-SULPHATE IN FIBRINOGEN AND FIBRIN.
Topics: Animals; Cattle; Chromatography; Fibrin; Fibrinogen; Horses; Research; Sulfates; Tyrosine; Ultraviolet Rays | 1963 |
THE AMINO ACID COMPOSITION OF BOVINE FIBRINOGEN.
Topics: Amides; Amino Acids; Anesthetics, Local; Animals; Autoanalysis; Cattle; Colorimetry; Fibrinogen; Hexoses; Nitrogen; Research; Tryptophan; Tyrosine | 1964 |
CHEMICAL ANALYSIS OF PROTEINS LOW IN AROMATIC AMINO-ACIDS.
Topics: Amino Acids, Aromatic; Animals; Blood Proteins; Cattle; Centrifugation; Chemical Precipitation; Fibrinogen; Galactose; Indicators and Reagents; Proteins; Research; Serum Albumin; Serum Albumin, Bovine; Spectrum Analysis; Tryptophan; Tyrosine | 1964 |
Involvement of the beta3 E749ATSTFTN756 region in stabilizing integrin alphaIIbbeta3-ligand interaction.
Topics: Animals; Blood Platelets; Cell Line; CHO Cells; Cricetinae; Cytoplasm; Cytoskeleton; Fibrinogen; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Ligands; Peptides; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Thrombin; Time Factors; Tyrosine | 2003 |
Thrombin binding to GPIbalpha induces integrin alphaIIbbeta3 dependent platelet adhesion to fibrin in ex vivo flowing whole blood.
Topics: Acetates; Anticoagulants; Blood; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Membrane Glycoproteins; Membrane Proteins; Oligopeptides; Peptide Fragments; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombin; Thrombosis; Tyrosine | 2004 |
Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Topics: Antibodies, Monoclonal; Blood Platelets; Collagen; Eptifibatide; Fibrinogen; Humans; Isoxazoles; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombin; Tirofiban; Tyrosine | 2004 |
SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha IIb beta 3 signaling in platelets.
Topics: Animals; Blood Platelets; Blotting, Western; Calcium; Cell Adhesion; Chromatography, High Pressure Liquid; Cytosol; Down-Regulation; Erythrocytes; Fibrinogen; Flow Cytometry; Gene Expression Regulation; Humans; Inositol Polyphosphate 5-Phosphatases; Integrins; Mice; Mice, Inbred C57BL; Phosphatidylinositol Phosphates; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoric Monoester Hydrolases; Phosphorylation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Precipitin Tests; Signal Transduction; src-Family Kinases; Time Factors; Tyrosine | 2004 |
Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways.
Topics: Blotting, Western; Calcium; Cells, Cultured; Cytoplasmic Granules; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinogen; Humans; Macrophage-1 Antigen; Mitogen-Activated Protein Kinases; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Phosphorylation; Signal Transduction; Tyrosine | 2004 |
Effects of tirofiban on acute systemic inflammatory response in elective percutaneous coronary interventions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocyte Count; Male; Middle Aged; Myocardium; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Troponin; Tumor Necrosis Factor-alpha; Tyrosine | 2004 |
Fibrinogen Mannheim II: a novel gamma307 His-->Tyr substitution in the gammaD domain causes hypofibrinogenemia.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Codon; DNA; DNA Mutational Analysis; Exons; Family Health; Female; Fibrinogen; Fibrinolysis; Heterozygote; Histidine; Humans; Male; Models, Molecular; Mutation; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Analysis, DNA; Spectrometry, Mass, Electrospray Ionization; Tyrosine | 2004 |
Peroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity.
Topics: Blotting, Western; Chromatography, Affinity; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinolysin; Glutathione; Inhibitory Concentration 50; Oxidants; Peroxynitrous Acid; Plasminogen; Spectrophotometry; Streptokinase; Time Factors; Tyrosine | 2004 |
Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies, Monoclonal; Antigens, CD; Calcium; Cell Adhesion; Cell Line; Fibrinogen; Fibronectins; Humans; Hypersensitivity; Immunoglobulin E; Mast Cells; Passive Cutaneous Anaphylaxis; Phosphoproteins; Phosphorylation; Platelet Membrane Glycoproteins; Protein Kinase C; Protein Kinase C-delta; Rats; Receptors, IgE; Serotonin; Signal Transduction; Tetraspanin 30; Tyrosine; Vitronectin | 2005 |
CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen.
Topics: 1-Phosphatidylinositol 4-Kinase; Actins; Antigens, CD; Blood Platelets; Cytoskeleton; Fibrinogen; Humans; Phosphorylation; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Protein Binding; Tetraspanin 30; Tyrosine | 2005 |
The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases.
Topics: Blood Platelets; Densitometry; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Immunoblotting; Integrin beta3; Leucine; Mitogen-Activated Protein Kinase 1; Models, Biological; Myosin Light Chains; Myosin-Light-Chain Phosphatase; Phosphorylation; Platelet Adhesiveness; Polymorphism, Genetic; Proline; Protein Isoforms; Protein Serine-Threonine Kinases; Signal Transduction; Threonine; Tyrosine | 2005 |
SHPS-1 negatively regulates integrin alphaIIbbeta3 function through CD47 without disturbing FAK phosphorylation.
Topics: Actinin; Animals; Antigens, CD; Antigens, Differentiation; Blood Platelets; CD47 Antigen; Cell Line; Cell Membrane; CHO Cells; Cortactin; Cricetinae; Dose-Response Relationship, Drug; Fibrinogen; Flow Cytometry; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation; Humans; Immunoblotting; Immunoprecipitation; Membrane Glycoproteins; Mice; Microfilament Proteins; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein-Tyrosine Kinases; Receptors, Immunologic; Signal Transduction; Tyrosine | 2005 |
Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
Topics: Adenosine Diphosphate; Aged; Binding, Competitive; Blood Platelets; Clopidogrel; Coronary Artery Disease; Data Interpretation, Statistical; Eptifibatide; Fibrinogen; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Iodine Radioisotopes; Male; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Topics: Antibodies, Monoclonal; Calcium; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Ligands; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Time Factors; Tirofiban; Tyrosine; von Willebrand Factor | 2005 |
Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?
Topics: Abciximab; Aged; Antibodies, Monoclonal; Blood Platelet Disorders; Blood Platelets; Cell Separation; Clopidogrel; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymers; Pyridines; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Ion-selective enrichment of tyrosine-sulfated peptides from complex protein digests.
Topics: Amino Acid Sequence; Chromatography, Ion Exchange; Fibrinogen; Mass Spectrometry; Molecular Sequence Data; Peptides; Protein Processing, Post-Translational; Sulfates; Tyrosine | 2005 |
Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
Topics: Abciximab; Acetates; Adenosine Diphosphate; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Blood Specimen Collection; Fibrinogen; Hemorheology; Humans; Immunoglobulin Fab Fragments; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Tyrosine | 2005 |
Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus.
Topics: Aged; Diabetes Mellitus; Female; Fibrinogen; Flow Cytometry; Humans; In Vitro Techniques; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2006 |
A role for PKCtheta in outside-in alpha(IIb)beta3 signaling.
Topics: Actins; Agammaglobulinaemia Tyrosine Kinase; Animals; Blood Platelets; Cell Shape; Cytoskeleton; Dose-Response Relationship, Drug; Fibrinogen; Humans; Intracellular Signaling Peptides and Proteins; Isoenzymes; Mice; Mice, Knockout; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein Kinase C-theta; Protein-Tyrosine Kinases; Signal Transduction; Syk Kinase; Tyrosine; Wiskott-Aldrich Syndrome Protein | 2006 |
Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.
Topics: Actinin; Blood Platelets; Catechin; Cell Survival; Cells, Cultured; Cyclic GMP; Fibrinogen; Guanylate Cyclase; Humans; Nitrates; Nitric Oxide Donors; Nitroprusside; Platelet Adhesiveness; Solubility; Superoxide Dismutase; Thrombin; Tyrosine | 2006 |
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2006 |
AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
Topics: Administration, Oral; Alanine; Amidines; Binding, Competitive; Blood Platelets; Dimerization; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Humans; In Vitro Techniques; Injections, Intravenous; Intercellular Signaling Peptides and Proteins; Isoxazoles; Kinetics; Male; Models, Molecular; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Pyrrolidines; Reference Values; Structure-Activity Relationship; Tirofiban; Tyrosine | 2007 |
Viscoelastic properties of fibrinogen adsorbed to the surface of biomaterials used in blood-contacting medical devices.
Topics: Adsorption; Biocompatible Materials; Blood; Disinfection; Elasticity; Equipment Design; Fibrinogen; Humans; Polycarboxylate Cement; Polymers; Prostheses and Implants; Sterilization; Surface Properties; Tyrosine; Viscosity | 2007 |
Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: evidence for cGMP-independent mechanisms.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Fibrinogen; Humans; Nitric Oxide; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Tyrosine | 2007 |
cGMP-independent inhibition of integrin alphaIIbbeta3-mediated platelet adhesion and outside-in signalling by nitric oxide.
Topics: Cell Adhesion; Cyclic GMP; Fibrinogen; Humans; Integrin beta3; Nitric Oxide; Nitric Oxide Donors; Phosphorylation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; S-Nitrosoglutathione; Signal Transduction; Tyrosine | 2007 |
Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.
Topics: Animals; Aorta; Apolipoprotein A-I; Atherosclerosis; Autoantibodies; Blood Coagulation; Blood Proteins; Cholesterol, HDL; Disease Models, Animal; Female; Fibrin; Fibrinogen; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Immunoelectron; Nitrogen; Oxidants; Proteomics; Tyrosine | 2007 |
Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Chickens; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Glycine; Humans; Lampreys; Lysine; Models, Molecular; Molecular Sequence Data; Oligopeptides; Protein Binding; Protein Conformation; Species Specificity; Tissue Plasminogen Activator; Tyrosine | 2007 |
Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.
Topics: Antibodies; Blood Platelets; Cell Adhesion; Cell Line; Collagen; Drug Evaluation, Preclinical; Fibrinogen; Humans; Models, Molecular; Molecular Structure; Platelet Membrane Glycoprotein IIb; Protein Structure, Tertiary; Tirofiban; Tyrosine | 2008 |
Tyr178 of beta3 is critical for alphaIIb maturation and macromolecular ligand binding to alphaIIbbeta3.
Topics: Animals; Cell Adhesion; CHO Cells; Cricetinae; Cricetulus; Epitopes; Fibrinogen; Humans; Ligands; Mutation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Tyrosine | 2008 |
Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Topics: Antithrombin III; beta-Thromboglobulin; Blood Platelets; Class I Phosphatidylinositol 3-Kinases; Extracorporeal Circulation; Fibrinogen; Granulocytes; Hemoglobins; Humans; Male; Microscopy, Electron, Scanning; Morpholines; Peptide Hydrolases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Protein Kinase Inhibitors; Pyrimidinones; Research Design; Stress, Mechanical; Time Factors; Tirofiban; Tyrosine | 2008 |
The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Shape; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Fibrinogen; Serotonin; Tirofiban; Tyrosine | 2008 |
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
Topics: Adolescent; Adult; Fibrin; Fibrinogen; Humans; Microscopy, Immunoelectron; Middle Aged; Nitrogen; Oxidative Stress; Protein Processing, Post-Translational; Protein Structure, Tertiary; Risk Factors; Thrombosis; Tyrosine | 2008 |
Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Cell Line; Conserved Sequence; Cricetinae; Eptifibatide; Fibrinogen; Humans; Mice; Molecular Sequence Data; Peptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Rats; Recombinant Proteins; Sequence Alignment; Tirofiban; Tyrosine | 2009 |
Characterization of static adhesion of human platelets in plasma to protein surfaces in microplates.
Topics: Abciximab; Albumins; Antibodies, Monoclonal; Blood Platelets; Collagen; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Peptides; Plasma; Platelet Adhesiveness; Platelet Aggregation; Proteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thromboxane A2; Tirofiban; Tyrosine | 2009 |
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine | 2010 |
The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
Topics: Blood Platelets; Blood Proteins; Cell Adhesion; Enzyme Inhibitors; Fibrinogen; Free Radical Scavengers; Guanylate Cyclase; Humans; Molsidomine; Nitrates; Peroxynitrous Acid; Solubility; Superoxides; Thrombin; Tyrosine | 2010 |
Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin.
Topics: Carbohydrates; Crystallography, X-Ray; Fibrinogen; Ficolins; Humans; Lectins; Mutagenesis, Site-Directed; Mutation, Missense; N-Acetylneuraminic Acid; Polysaccharides; Protein Array Analysis; Protein Binding; Tyrosine | 2010 |
Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage.
Topics: Animals; Arterioles; Blotting, Western; Caspase 3; Cerebral Arteries; Fibrinogen; Immunohistochemistry; In Situ Nick-End Labeling; Intracranial Thrombosis; Lac Operon; Mice; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Subarachnoid Hemorrhage; Superoxides; Tyrosine; Vasospasm, Intracranial | 2011 |
Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin.
Topics: Adsorption; Antibodies, Monoclonal; Circular Dichroism; Fatty Alcohols; Fibrinogen; Gold; Humans; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Conformation; Protein Structure, Secondary; Serum Albumin; Silicones; Sulfhydryl Compounds; Tirofiban; Tyrosine | 2011 |
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
Topics: Arginine; Blood Platelets; Drug Design; Drug Evaluation, Preclinical; Fibrinogen; Fluorescein-5-isothiocyanate; Humans; Isoquinolines; Ligands; Oligopeptides; Phthalimides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Fibrinogen; Software; Stereoisomerism; Structure-Activity Relationship; Tirofiban; Tyrosine | 2011 |
Targeted gene inactivation reveals a functional role of calpain-1 in platelet spreading.
Topics: Animals; Blood Platelets; Calpain; cdc42 GTP-Binding Protein; Cell Adhesion; Cell Shape; Collagen; Enzyme Activation; Fibrinogen; Gene Silencing; Genotype; Hemostasis; Humans; Mice; Mice, Knockout; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Microscopy, Interference; Phenotype; Phosphorylation; Protease Inhibitors; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; rac1 GTP-Binding Protein; Recombinant Proteins; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Substrate Specificity; Time Factors; Tyrosine | 2012 |
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: part 2.
Topics: Cell Adhesion; Cell Survival; Fibrinogen; Fibronectins; Humans; Integrin alpha5beta1; K562 Cells; Models, Molecular; Molecular Mimicry; Oligopeptides; Serum Albumin; Structure-Activity Relationship; Tyrosine | 2012 |
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: part 1.
Topics: Cell Adhesion; Cell Survival; Fibrinogen; Fibronectins; Humans; Integrin alpha5beta1; K562 Cells; Models, Molecular; Molecular Mimicry; Oligopeptides; Serum Albumin; Structure-Activity Relationship; Tyrosine | 2012 |
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
Topics: Animals; Arterioles; Blood Platelets; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine; Veins | 2013 |
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
Topics: Afibrinogenemia; Aspartic Acid; Binding Sites; Chromatography, High Pressure Liquid; Dimerization; Fibrinogen; Gene Deletion; Genetic Variation; Histidine; Humans; Infant; Male; Mutation; Phenotype; Sequence Analysis, DNA; Thrombosis; Tyrosine | 2013 |
An effect of glycoprotein IIb/IIIa inhibitors on the kinetics of red blood cells aggregation.
Topics: Adult; Antibodies, Monoclonal; Blood Platelets; Cell Communication; Eptifibatide; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Humans; Kinetics; Ligands; Optics and Photonics; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine; Young Adult | 2014 |
Effects of Mn (II) on peroxynitrite nitrifying fibrinogen.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Cattle; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Glycoproteins; Manganese; Nitrogen; Peroxynitrous Acid; Spectrometry, Fluorescence; Thrombin; Time Factors; Tyrosine | 2014 |
Direct identification of tyrosine sulfation by using ultraviolet photodissociation mass spectrometry.
Topics: Amino Acid Sequence; Animals; Cattle; Ceruletide; Chromatography, High Pressure Liquid; Databases, Chemical; Electrochemical Techniques; Enkephalin, Leucine; Fibrinogen; Humans; Lasers; Limit of Detection; Mass Spectrometry; Microchemistry; Neuropeptides; Oligopeptides; Peptide Fragments; Photoelectron Spectroscopy; Protein Processing, Post-Translational; Sulfates; Tandem Mass Spectrometry; Tyrosine | 2014 |
A central role for intermolecular dityrosine cross-linking of fibrinogen in high molecular weight advanced oxidation protein product (AOPP) formation.
Topics: Advanced Oxidation Protein Products; Arginine; Blotting, Western; Cross-Linking Reagents; Dose-Response Relationship, Drug; Fibrinogen; Humans; Hypochlorous Acid; Lysine; Molecular Weight; Oxidation-Reduction; Protein Carbonylation; Serum Albumin; Tyrosine | 2015 |
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Brain; Brain Ischemia; Caspase 3; Cell Line, Tumor; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neurons; Rats; Rats, Sprague-Dawley; Stroke; Tyrosine | 2015 |
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.
Topics: Amino Acid Motifs; Apoptosis; Blood Platelets; Collagen; Endothelial Cells; Fibrinogen; Fusion Proteins, bcr-abl; Humans; Imidazoles; Immunoreceptor Tyrosine-Based Activation Motif; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Activation; Platelet Aggregation; Pyridazines; Shear Strength; Signal Transduction; Tyrosine | 2015 |
Haem-assisted dityrosine-cross-linking of fibrinogen under non-thermal plasma exposure: one important mechanism of facilitated blood coagulation.
Topics: Blood Cells; Blood Coagulation; Coordination Complexes; Cross-Linking Reagents; Fibrinogen; Heme; Hemin; Humans; Iron; Plasma Gases; Primary Cell Culture; Tyrosine | 2016 |
Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
Topics: Blood Coagulation; Fibrinogen; Humans; Nitric Oxide Donors; Nitrosative Stress; Nitroso Compounds; Oxidation-Reduction; Protein Carbonylation; Thrombin; Tyrosine | 2017 |
Thiol oxidation and di-tyrosine formation in human plasma proteins induced by inflammatory concentrations of hypochlorous acid.
Topics: Apolipoprotein A-I; Biomarkers; Blood Proteins; Blood Specimen Collection; Complement C3; Fibrinogen; Humans; Hypochlorous Acid; Inflammation; Mass Spectrometry; Oxidation-Reduction; Oxidative Stress; Peroxidase; Protein Aggregates; Sulfhydryl Compounds; Tyrosine | 2017 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Identification and relative quantification of 3-nitrotyrosine residues in fibrinogen nitrated in vitro and fibrinogen from ischemic stroke patient plasma using LC-MS/MS.
Topics: Brain Ischemia; Chromatography, Liquid; Fibrinogen; Hemostatics; Humans; Ischemic Stroke; Nitrates; Stroke; Tandem Mass Spectrometry; Tyrosine | 2021 |